You have 9 free searches left this month | for more free features.

City

Bordeau (1)

Essen (1)

Houston (1)

Strasbourg (1)

Condition

Acute Ischemic Stroke (2)

ARDS (1)

Acute Respiratory Distress Syndrome (1)

COVID-19 (1)

SARS-CoV Infection (1)

Stroke, Acute (1)

Stroke, Ischemic (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2/phase 3 (2)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Acticor Biotech (3)

Assistance Publique - Hopitaux de Paris (1)

Collaborator

Intervention

glenzocimab (2)

intravenous placebo (2)

placebo (2)

intravenous act017 1000 mg (1)

intravenous glenzocimab (act017) 1000 mg (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

glenzocimab

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Stroke, Acute, Stroke, Ischemic Trial (Glenzocimab, Placebo)

Not yet recruiting

Stroke, Acute
Stroke, Ischemic

Glenzocimab
Placebo

(no location specified)

Sep 26, 2022

Acute Ischemic Stroke Trial in Bordeau (Intravenous glenzocimab (ACT017) 1000 mg, Intravenous Placebo)

Recruiting

Acute Ischemic Stroke

Intravenous glenzocimab (ACT017) 1000 mg
Intravenous Placebo

Houston, Texas
+1 more

Sep 28, 2022

SARS-CoV Infection, Acute Respiratory Distress Syndrome, COVID-19 Trial in Strasbourg (glenzocimab, Placebo)

Completed

SARS-CoV Infection
+3 more

glenzocimab
Placebo

Strasbourg, France

Hôpital de Hautepierre

Sep 10, 2021

Acute Ischemic Stroke Trial in Bordeau (Intravenous ACT017 1000 mg, Intravenous Placebo)

Completed

Acute Ischemic Stroke

Intravenous ACT017 1000 mg
Intravenous Placebo

Bordeau, France

Centre Hospitalier Universitaire de Bordeaux,

Oct 5, 2021